CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of 688513 for the last quarter is 310.06 M CNY, and it's 17.91% higher compared to the previous quarter. The net income of Q1 24 is 75.01 M CNY.